| Identification | Back Directory | [Name]
DC 102 antibiotic | [CAS]
115722-50-4 | [Synonyms]
DC-102
DC 102 antibiotic
Antibiotic DC-102
7-[[3-C-Methyl-4-(methylamino)-4,6-dideoxy-α-L-mannopyranosyl]oxy]-1,2,3,10,11,11a-hexahydro-11-methoxy-2-propylidene-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one, 7-[[4,6-dideoxy-3-C-methyl-4-(methylamino)-α-L-mannopyranosyl]oxy]-1,2,3,10,11,11a-hexahydro-11-methoxy-2-propylidene- (9CI) | [Molecular Formula]
C24H35N3O6 | [MOL File]
115722-50-4.mol | [Molecular Weight]
461.56 |
| Hazard Information | Back Directory | [Description]
DC 102 Antibiotic is also known as DC 102, it is a new glycosidic pyrrolo(1,4)benzodiazepine antibiotic produced by Streptomyces sp. | [Uses]
Antibiotic DC 102 is a new glycosidic pyrrole(1,4)benzodiazepine antibiotic with a MIC value of 42 μg/mL target Bacillus subtilis No. 10707. Antibiotic DC 102 has an LD50 value of 1.5mg/mL(i.p) in mouse[1]. | [References]
[1] M Hara, et al. DC 102, a new glycosidic pyrrolo(1,4)benzodiazepine antibiotic produced by Streptomyces sp. J Antibiot (Tokyo). 1988 May;41(5):702-4. DOI:10.7164/antibiotics.41.702 |
|
|